MGNX
MACROGENICS INC
NASDAQ · Healthcare · Biotechnology · US
$4.14
+0.24%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $39.2M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- $0.31
- EPS estimate
- -$0.08
- Revenue actual
- $32.8M
- Revenue estimate
- $59.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +142.8%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.08 | $0.31 | Beat 498.15% | $32.8M |
| May 14, 2026 | -$0.57 | -$0.58 | Miss -1.75% | $20.8M |
| Mar 9, 2026 | -$0.12 | -$0.22 | Miss -81.32% | $41.2M |
| Nov 12, 2025 | -$0.48 | $0.27 | Beat 156.25% | $72.8M |
| Aug 14, 2025 | -$0.59 | -$0.57 | Beat 3.39% | $22.2M |
| Mar 20, 2025 | -$0.23 | -$0.25 | Miss -8.70% | $17.7M |
| May 9, 2024 | -$0.67 | -$0.84 | Miss -25.37% | $9.1M |
| Mar 7, 2024 | -$0.26 | -$0.75 | Miss -188.46% | $10.7M |
| Mar 15, 2023 | $0.10 | $0.21 | Beat 110.00% | $71.2M |
| Nov 3, 2022 | -$0.49 | -$0.40 | Beat 18.37% | $41.7M |
| May 3, 2022 | -$0.84 | -$1.08 | Miss -28.57% | $10.7M |
| Feb 24, 2022 | -$0.83 | -$0.95 | Miss -14.46% | $13.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026